Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact
Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: TET1

Gene summary for TET1

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

TET1

Gene ID

80312

Gene nametet methylcytosine dioxygenase 1
Gene AliasCXXC6
Cytomap10q21.3
Gene Typeprotein-coding
GO ID

GO:0001701

UniProtAcc

Q8NFU7


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
80312TET1PTC05HumanThyroidPTC1.26e-113.96e-010.2065
80312TET1PTC07HumanThyroidPTC1.21e-041.02e-010.2044
80312TET1ATC12HumanThyroidATC4.25e-142.86e-010.34
80312TET1ATC13HumanThyroidATC7.21e-446.86e-010.34
80312TET1ATC4HumanThyroidATC7.37e-163.82e-010.34
80312TET1ATC5HumanThyroidATC2.11e-467.42e-010.34
Page: 1 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:00064866ThyroidPTCprotein glycosylation94/5968226/187231.25e-037.13e-0394
GO:00434136ThyroidPTCmacromolecule glycosylation94/5968226/187231.25e-037.13e-0394
GO:0031507ThyroidPTCheterochromatin assembly22/596839/187231.32e-037.47e-0322
GO:00018246ThyroidPTCblastocyst development49/5968106/187231.37e-037.72e-0349
GO:00458142ThyroidPTCnegative regulation of gene expression, epigenetic26/596850/187232.44e-031.27e-0226
GO:00708282ThyroidPTCheterochromatin organization24/596846/187233.34e-031.63e-0224
GO:00700855ThyroidPTCglycosylation96/5968240/187234.57e-032.15e-0296
GO:00091013ThyroidPTCglycoprotein biosynthetic process123/5968317/187235.05e-032.33e-02123
GO:00091003ThyroidPTCglycoprotein metabolic process147/5968387/187235.87e-032.64e-02147
GO:00609688ThyroidPTCregulation of gene silencing36/596881/187231.18e-024.64e-0236
GO:001657017ThyroidATChistone modification243/6293463/187232.23e-172.27e-15243
GO:004670024ThyroidATCheterocycle catabolic process228/6293445/187237.26e-154.50e-13228
GO:004427025ThyroidATCcellular nitrogen compound catabolic process229/6293451/187232.25e-141.27e-12229
GO:001943924ThyroidATCaromatic compound catabolic process232/6293467/187233.05e-131.44e-11232
GO:190136124ThyroidATCorganic cyclic compound catabolic process238/6293495/187231.12e-114.12e-10238
GO:000170126ThyroidATCin utero embryonic development183/6293367/187236.62e-112.11e-09183
GO:003105616ThyroidATCregulation of histone modification85/6293152/187231.23e-082.55e-0785
GO:0006325110ThyroidATCchromatin organization189/6293409/187236.40e-081.13e-06189
GO:003105811ThyroidATCpositive regulation of histone modification52/629392/187235.21e-065.61e-0552
GO:009872722ThyroidATCmaintenance of cell number70/6293134/187236.45e-066.69e-0570
Page: 1 2 3 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
Page: 1 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
TET1ECMLungAAHGPR137C,AP001636.3,PLEKHA7, etc.4.29e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TET1ECMLungADJGPR137C,AP001636.3,PLEKHA7, etc.3.95e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TET1MYOFIBLungADJGPR137C,AP001636.3,PLEKHA7, etc.1.81e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TET1FIBLungADJGPR137C,AP001636.3,PLEKHA7, etc.1.29e-02The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TET1ECMLungAISGPR137C,AP001636.3,PLEKHA7, etc.4.29e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TET1FIBLungIACGPR137C,AP001636.3,PLEKHA7, etc.2.65e-02The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TET1MYOFIBLungIACGPR137C,AP001636.3,PLEKHA7, etc.3.10e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TET1ECMLungMIACGPR137C,AP001636.3,PLEKHA7, etc.3.90e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
TET1SNVMissense_Mutationnovelc.3184N>Ap.Asp1062Asnp.D1062NQ8NFU7protein_codingtolerated(0.2)benign(0.006)TCGA-3C-AALI-01Breastbreast invasive carcinomaFemale<65I/IIUnspecificPoly EComplete Response
TET1SNVMissense_Mutationrs778536892c.23G>Ap.Arg8Lysp.R8KQ8NFU7protein_codingtolerated(0.49)benign(0.018)TCGA-A2-A0T0-01Breastbreast invasive carcinomaFemale<65I/IIChemotherapytaxotereSD
TET1SNVMissense_Mutationnovelc.4185T>Ap.Phe1395Leup.F1395LQ8NFU7protein_codingtolerated(0.06)probably_damaging(0.997)TCGA-A7-A0CG-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
TET1SNVMissense_Mutationc.1580C>Tp.Ser527Leup.S527LQ8NFU7protein_codingtolerated(0.12)benign(0)TCGA-A8-A0A7-01Breastbreast invasive carcinomaFemale<65I/IIUnknownUnknownSD
TET1SNVMissense_Mutationnovelc.3095N>Tp.Ser1032Phep.S1032FQ8NFU7protein_codingtolerated(0.09)benign(0.021)TCGA-AC-A3BB-01Breastbreast invasive carcinomaFemale<65III/IVChemotherapycytoxanCR
TET1SNVMissense_Mutationnovelc.554N>Ap.Ser185Asnp.S185NQ8NFU7protein_codingtolerated(0.15)possibly_damaging(0.459)TCGA-AN-A046-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
TET1SNVMissense_Mutationnovelc.984N>Cp.Lys328Asnp.K328NQ8NFU7protein_codingdeleterious(0.04)benign(0.007)TCGA-AN-A046-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
TET1SNVMissense_Mutationrs538486517c.1452N>Tp.Glu484Aspp.E484DQ8NFU7protein_codingdeleterious(0.02)benign(0.28)TCGA-AN-A046-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
TET1SNVMissense_Mutationrs369109149c.2234N>Ap.Arg745Glnp.R745QQ8NFU7protein_codingtolerated(0.59)benign(0)TCGA-AN-A046-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
TET1SNVMissense_Mutationnovelc.2594N>Cp.Lys865Thrp.K865TQ8NFU7protein_codingtolerated(0.12)benign(0.01)TCGA-AN-A046-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1